Heparin‐Based Nanoparticles for Targeted Anti‐Tumor Therapy by Efficient Ferroptosis
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.70261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Jianquan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Engineering, Jinling Institute of Technology, Nanjing, China. Hauptthemen laut MEDLINE: Ferroptosis, Heparin, Nanoparticles, Antineoplastic Agents. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Foundation of the, Jinling Institute of Technology, National Lab of Solid State Microstructures.
Abstract (Originalsprache)
Ferroptosis is an iron‐dependent programmed cell death driven by lipid peroxidation that has been implicated in the pathogenesis of various diseases, especially lethal cancers. Numerous studies have suggested that ferroptosis serves as a bona fide target for antitumor therapies. However, therapeutic efficacy and tumor‐targeting capacity still need to be improved, and the underlying mechanisms need to be studied and illustrated. In this study, a nanoformulation of folate‐acid‐decorated Fe‐loaded heparin nanoparticles was rationally designed with the intention of facilitating tumor accumulation for antitumor therapy, with efficient ferroptosis efficacy. The results of both in vitro and in vivo experiments indicated that the nanomedication used in this study could provide an effective antitumor system with efficient ferroptosis capacity and satisfactory biosafety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials Engineering, Jinling Institute of Technology, Nanjing, China.
- Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, China.
- Wuxi Xishan NJU Institute of Applied Biotechnology, Wuxi, China.
- Department of Medical Imaging, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China.
ORCID-Profile: Jianquan Wang, Diya Xie, Danni Shan, Zhiyong Wang
Förderung
- Foundation of the
- Jinling Institute of Technology
- National Lab of Solid State Microstructures
- Nanjing University
Zitieren
APA
Wang, J., Xie, D., Shan, D., Cheng, Y., Hu, J., & Wang, Z. (2026). Heparin‐Based Nanoparticles for Targeted Anti‐Tumor Therapy by Efficient Ferroptosis. Macromolecular Bioscience. https://doi.org/10.1002/mabi.70261
Vancouver
Wang J, Xie D, Shan D, Cheng Y, Hu J, Wang Z. Heparin‐Based Nanoparticles for Targeted Anti‐Tumor Therapy by Efficient Ferroptosis. Macromolecular Bioscience. 2026. doi:10.1002/mabi.70261
BibTeX
@article{Wang2026,
author = {Wang, Jianquan and Xie, Diya and Shan, Danni and Cheng, Yuan and Hu, Jing and Wang, Zhiyong},
title = {Heparin‐Based Nanoparticles for Targeted Anti‐Tumor Therapy by Efficient Ferroptosis},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.70261}
}
EUVIMED